These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17256466)

  • 1. Migrastatin acts as a muscarinic acetylcholine receptor antagonist.
    Nakae K; Nishimura Y; Ohba S; Akamatsu Y
    J Antibiot (Tokyo); 2006 Nov; 59(11):685-92. PubMed ID: 17256466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel migrastatin and dorrigocin A analogues from D-glucal.
    Anquetin G; Rawe SL; McMahon K; Murphy EP; Murphy PV
    Chemistry; 2008; 14(5):1592-600. PubMed ID: 18038383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of multidrug resistance by migrastatin.
    Takemoto Y; Tashiro E; Imoto M
    J Antibiot (Tokyo); 2006 Jul; 59(7):435-8. PubMed ID: 17025021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new enzymic method for the isolation and culture of human bladder body smooth muscle cells.
    Ma F-; Higashira H; Ukai Y; Hanai T; Kiwamoto H; Park YC; Kurita T
    Neurourol Urodyn; 2002; 21(1):71-9. PubMed ID: 11835427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ mobilization and activation of extracellular acidification by carbachol in acutely dispersed cells from guinea pig detrusor: Fura 2 fluorometry and microphysiometry using the cytosensor.
    Ikeda K; Kobayashi S; Suzuki M; Miyata K; Yamada T; Honda K
    Life Sci; 1999; 65(15):1569-77. PubMed ID: 10574223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies.
    Cha S; Singson E; Cornelius J; Yagna JP; Knot HJ; Peck AB
    J Rheumatol; 2006 Feb; 33(2):296-306. PubMed ID: 16465661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective binding of bladder muscarinic receptors in relation to the pharmacokinetics of a novel antimuscarinic agent, imidafenacin, to treat overactive bladder.
    Yamada S; Seki M; Ogoda M; Fukata A; Nakamura M; Ito Y
    J Pharmacol Exp Ther; 2011 Feb; 336(2):365-71. PubMed ID: 21047953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potent cell migration inhibitors through total synthesis: lessons from structure-activity studies of (+)-migrastatin.
    Njardarson JT; Gaul C; Shan D; Huang XY; Danishefsky SJ
    J Am Chem Soc; 2004 Feb; 126(4):1038-40. PubMed ID: 14746469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects in muscarinic receptor cell signaling in bladder urothelial cancer cell lines.
    Tully BT; Li M; Sun Y; Berkowitz J; Chai TC
    Urology; 2009 Aug; 74(2):467-73. PubMed ID: 19573899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of muscarinic receptor subtypes of cultured smooth muscle cells and tissue of human bladder body.
    Kiwamoto H; Ma FH; Higashira H; Park YC; Kurita T
    Int J Urol; 2001 Oct; 8(10):557-63. PubMed ID: 11737484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term regulation of muscarinic acetylcholine receptor binding in cultured nerve cells.
    Feigenbaum P; El-Fakahany EE
    Res Commun Chem Pathol Pharmacol; 1984 Mar; 43(3):519-22. PubMed ID: 6718813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo demonstration of muscarinic receptor binding activity of N-desethyl-oxybutynin, active metabolite of oxybutynin.
    Oki T; Kawashima A; Uchida M; Yamada S
    Life Sci; 2005 Apr; 76(21):2445-56. PubMed ID: 15763076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor.
    Tyagi S; Tyagi P; Van-le S; Yoshimura N; Chancellor MB; de Miguel F
    J Urol; 2006 Oct; 176(4 Pt 1):1673-8. PubMed ID: 16952712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction pathways of muscarinic receptor mediated activation in the newborn and adult mouse urinary bladder.
    Ekman M; Andersson KE; Arner A
    BJU Int; 2009 Jan; 103(1):90-7. PubMed ID: 18727613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological effects of solifenacin on human isolated urinary bladder.
    Masunaga K; Yoshida M; Inadome A; Murakami S; Sugiyama Y; Satoji Y; Maeda Y; Ueda S
    Pharmacology; 2008; 82(1):43-52. PubMed ID: 18434763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotropic receptor-activated calcium increases and store-operated calcium influx in mouse Müller cells.
    Da Silva N; Herron CE; Stevens K; Jollimore CA; Barnes S; Kelly ME
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3065-73. PubMed ID: 18316702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
    Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE
    BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line.
    Cabadak H; Küçükibrahimoğlu E; Aydin B; Kan B; Zafer Gören M
    Auton Autacoid Pharmacol; 2009 Jul; 29(3):109-15. PubMed ID: 19364336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional muscarinic M2 and M3 receptors and beta-adrenoceptor in cultured rat bladder smooth muscle.
    Ma FH; Higashira-Hoshi H; Itoh Y
    Life Sci; 2002 Jan; 70(10):1159-72. PubMed ID: 11848300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine modulation of muscarinic receptors in the murine intestine.
    Akiho H; Khan WI; Al-Kaabi A; Blennerhassett P; Deng Y; Collins SM
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G250-5. PubMed ID: 17431212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.